RGCC scientists have developed a new anti-cancer dietary supplement that’s 34% more effective than the leading brand. Led by RGCC’s Dr Ioannis Papasotiriou, the new product offers yet more evidence of the potential for dietary supplements in the battle against cancer. It also demonstrates RGCC’s cutting-edge research and discovery capabilities. Genistein is a naturally occurring […]
Researchers have developed an effective vaccine that re-engineers cells from a patient’s tumour to target and destroy cancer cells. The results, published in the peer-reviewed Journal of Clinical Oncology, show that 45% of patients treated with an autologous cell vaccine, created from their own cancer cells, had a confirmed anti-tumour response. The findings provide more […]
US researchers have developed the first systemic way to catch and release cancer-killing packets, called exomes. Thousands of times smaller than natural killer (NK) cells, natural killer exomes can better penetrate cancer cells and destroy them. The authors hope that the ability to capture NK exomes could lead to more advanced and personalised treatments for […]
Researchers have developed a new method for assessing whether genetic mutations, passed from parent to child, increase cancer risk. They have identified 1146 genes, called cancer heritability genes (CHGs) that may increase a person’s likelihood of developing cancer during life. The new test could improve early diagnosis and the development of better-targeted treatments for patients. […]
Researchers have developed a new method for identifying biomarkers that could improve diagnosis and improve outcomes for patients. The Cell Heterogeneity-Adjusted cLonal Methylation (CHALM) method developed by scientists enables them to identify biomarkers that may be missed by traditional techniques, potentially leading to more accurate tests for diagnosing cancer. DNA methylation is a genetic process […]
Scientists have discovered that combining two existing forms of immunotherapy together is more effective at treating lung cancer. Working together, the two therapies deliver a one-two punch, targeting and then destroying lung tumour cells. The two-step therapy uses a patients’ immune cells to fight cancer. Scientists extract these “natural killers” from a patients’ tumour or […]
In the biggest research project of its type ever completed, a European research team has analysed DNA samples from over 100,000 women and identified nine specific genes associated with breast cancer risk. Scientists and experts believe findings could help improve screening and the development of new, personalised treatments for the disease. In an incredible and […]
Circulating tumour cells (CTCs) can play a crucial role in improving treatments for metastatic breast cancer, scientists have found. The simple blood test can provide clinicians with a reliable predictor of whether a treatment will be successful in less than a month, an audience at the 2020 San Antonio Breast Cancer Symposium heard in December. […]
UK scientists have discovered that liquid biopsy tests are 99% accurate at picking up crucial genetic mutations in patients with returning breast cancer. Researchers studying the potential for liquid biopsies have concluded that circulating tumour DNA (ctDNA) testing can provide an accurate genomic profile of advanced cancer, without the need for an invasive and potentially […]
The UK’s National Health Service (NHS) is to trial a liquid biopsy test that can identify up to 50 forms of cancer. Set to begin in 2021, the pilot project will assess how accurate and effective liquid biopsy testing is at diagnosing the disease. If successful, liquid biopsy testing could be rolled out across the […]
A US study of 3,000 cancer patients discovered that 13.5% had an inherited genetic mutation that caused their disease. In most cases, these mutations wouldn’t have been detected by clinicians using a standard guideline-based approach, leaving relatives unaware that they could be at an increased risk of developing cancer in the future. The discovery provides […]
Liquid biopsies have the potential to “substantially help to improve diagnosis” of breast cancer in women, a new study has found. Researchers writing in EBioMedicine (published by world-leading publisher The Lancet) found that “the clinical validity of liquid biopsy in the early breast cancer setting is more than evident.” Liquid biopsy techniques involve analysing a […]
